The UW Medicine Regional Heart Center Cardio-Oncology Clinic provides care to patients in all stages of cancer treatment who have or are at increased risk for heart disease. The clinic incorporates a multidisciplinary team of doctors and advanced providers to minimize cardiotoxicity during cancer treatment and reduce cardiovascular risk in cancer survivors.

Why is this important?

Based on current estimates, 13.7 million patients in the United States have a history of cancer (either in remission or undergoing treatment), and approximately 1.7 million new cases are diagnosed annually. Owing to significant progress in diagnostic and treatment capabilities over the past few decades, a sizable proportion of these individuals have a good chance of long-term survival. Cancer can now be viewed as a chronic manageable disease similar to diabetes or hypertension. It requires not only early detection, periodic surveillance and appropriate therapy, but optimal management of comorbid conditions.

Download Cardio-Oncology Overview for Referring Providers (PDF).

Cardio-oncology has emerged as a unique interface between the fields of oncology and cardiology. Cardiovascular events are increasingly being recognized as major sources of morbidity and mortality in cancer survivors, either from direct cardiotoxicity of chemotherapeutic agents or the presence of underlying concomitant cardiovascular conditions. Cancer can impact the cardiovascular system in numerous ways ranging from direct invasion of cardiac structures from primary or metastatic tumors of the heart to increased physiological stress for patients with established cardiac disease to acute or delayed cardiotoxicity of chemotherapy or radiation.

Cardio-Oncology Clinic Providers